Mereo BioPharma Group
D

MREO

0.28000
USD
-0.00
(-0.18%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
3,706
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
44,713,472
أصول ذات صلة

العنوان: Mereo BioPharma Group plc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its tworare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

أسئلة شائعة حول سهم Mereo BioPharma Group